RF
44
10
MRK
25
2
MMC
46
5
HBI
53
4
MMM
35
3
EQR
33
6
MHK
25
5
USB
50
3
ED
39
8
NEE
39
9
GE
60
5
DTE
49
16
CMS
57
2
WBA
41
3
AMGN
42
14
ZBH
69
15
OMC
37
2
SRE
37
9
AN
49
2
APH
53
3
RF
44
10
MRK
25
2
MMC
46
5
HBI
53
4
MMM
35
3
EQR
33
6
MHK
25
5
USB
50
3
ED
39
8
NEE
39
9
GE
60
5
DTE
49
16
CMS
57
2
WBA
41
3
AMGN
42
14
ZBH
69
15
OMC
37
2
SRE
37
9
AN
49
2
APH
53
3
Financhill
Back

Royalty Pharma PLC Vs. Nukkleus Industry Stock Comparison

Sell
32

RPRX
Royalty Pharma PLC

Last Price:
$24.97
Seasonality Move:
1.44%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
32
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $24.94. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $24.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 39.23 Sell
Chaikin Money Flow: 5676845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.09 - 26.47) Sell
Bollinger Bands (100): (26.05 - 28.27) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.88 Buy
20-day SMA: 25.71 Sell
50-day SMA: 26.45 Sell
200-day SMA: 27.59 Sell
8-day EMA: 24.95 Sell
20-day EMA: 25.48 Sell
50-day EMA: 26.23 Sell
200-day EMA: 27.55 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.22 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):